News

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has successfully developed a ...
Key Takeaways Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often ...
Oxaliplatin is a common colon cancer chemotherapy drug which costs $3,000 to $6,000 per treatment — cheap in the context of cancer care. The drug delivers an overall 10-year survival boost of 5%.
Leader and Health The discovery that cancer hacks nerves could lead to fairer treatments With rising cancer rates, we need more good news, and the latest finding that cancer interacts with the ...
Radiation oncologists at UH Seidman Cancer Center have another powerful treatment option for patients diagnosed with many forms of cancer with the addition of Varian Ethos 2.0, capable of a new ...
Cancer that responds to treatment with platinum-based drugs, such as cisplatin and carboplatin, is called “platinum sensitive,” according to the National Cancer Institute. Some cancers that return ...
Blood cancer patients in England are set to be among the first in the world to access a pioneering "Trojan horse" treatment, health officials have announced. The targeted therapy, belantamab ...